tert-Butyl 4-amino-3,3-difluoropyrrolidine-1-carboxylate, 95.0%, 100mg

3-Chloromethyl-5-(4-chlorophenyl)-[1,2,4]oxadiazole, 95.0%, 1g

Mubritinib, 99%, 10mg

2-[cyclohexyl({[(9h-fluoren-9-yl)methoxy]carbonyl})amino]acetic acid, 95%, 500mg

3-Methylpyridine-2,6-diamine, 95.0%, 250mg

2-((2-(4-Bromophenyl)-6-methylpyrimidin-4-yl)amino)ethanol, 98+%, 1g

n-Pentyl sulfonyl chloride, 95.0%, 10g

4-Methyl-6-methylsulfanyl-pyridine-3-carbaldehyde, 97%, 250mg

tert-butyl methyl ether, min. 99.5%, for synthesis, 1 l, glass packaging

Ethyl 1H-pyrrolo[3,2-b]pyridine-2-carboxylate, 95.0%, 10g

Tri-lithium phosphate, min. 99%, pure, 500 g, plastic packaging.

4-Bromo-6-(trifluoromethyl)-1H-indole, 95.0%, 5g

[2-(methoxymethoxy)phenyl](pyridin-3-yl)methanone, 95.0%, 5g